Microscopic distribution of misonidazole in mouse tissues. by Cobb, L. M. et al.
B e 5 The Macmillan Press Ltd., 1989
Microscopic distribution of misonidazole in mouse tissues
L.M. Cobb, J. Nolan & P. O'Neill
Division of Experimental Pathology and Therapeutics, MRC Radiobiology Unit, Chilton, Didcot, Oxon OXJJ ORD, UK.
Sunmnary Mice were injected with tritiated misonidazole (750mgkg-1), killed after 24h and the excised
tissues prepared for autoradiography (ARG) to identify sites of accumulation. The previously reported high
grain count associated with bound misonidazole metabolite(s) was observed in the liver. The ratio of grain
count in the emulsion above the centrilobular hepatocytes to the count over connective tissue (stroma) was
12. A higher count ratio for 'target' cells to stroma was observed in the following cells/tissues: meibomian
gland (ducts 110, acini 65), oesophagus (keratinised layer 60), incisor (enamel organ 17), nasal septum
(subepithelial glands 13). For some of these tissues the explanation might appear to lie with localised hypoxia,
but for others which were probably normoxic there is as yet no obvious reason for these findings.
Misonidazole (MISO) sensitises hypoxic cells to the effects of
ionising radiation. Further, its reduced metabolite(s) can
bind firmly to these cells, which are commonly found in
tumours (Garrecht & Chapman, 1983; Brown, 1975). The
metabolic steps which lead to this binding are incompletely
understood (Franko et al., 1982; Mason, 1982), but they
lead, subsequent to an at least two-electron nitroreduction,
to covalent binding to adjacent cellular macromolecules
(Varghese & Whitmore, 1980; Chapman et al., 1983; Rauth,
1984).
Although MISO was initially shown in mice to be an
efficient radiosensitiser of tumour cells subsequent clinical
trials revealed neurotoxicity at a dose level below that
required for tumour radiosensitisation. MISO will also
chemosensitise tumours, and the preferential binding of
radionuclide-labelled MISO in the hypoxic regions of
tumours points to the potential use of suitable derivatives in
tumour imaging (Urtasun et al., 1986). The presence of
hypoxic areas in many tumours has led to the suggestion
that anticancer drugs could be developed which would be
activated by the hypoxic environment, i.e. bioreductive drugs
(Hall & Roizin-Towle, 1975).
In the present work we have sought to identify those
normal tissues which might, like tumours, have cells which
accumulate MISO metabolites. Such accumulation could
arise from hypoxia, a high reductase activity or some other
mechanism. The skin, liver, intestine and cartilage are
normal tissues which on occasion have been reported to have
a low oxygen tension (Hendry, 1979; Bohlen, 1980; Langler
et al., 1982). The accumulation of metabolites of radio-
sensitisers or bioreductive drugs in any quantity in normal
healthy tissues might well cause problems when these com-
pounds are used in diagnosis or therapy.
MISO, labelled with tritium in the side chain, was injected
into mice and the microscopic distribution in tissues 24h
later was examined by ARG. The advantage of 3H over the
available alternative of 14C (ring label) in ARG is that the
shorter pathlength of the tritium fl-particle allows more
precise localisation of the cells containing the adduct(s). In
the present study it is likely that the observed activity
(grains) was due to metabolites of MISO that had been
bound covalently, as the experimental animals were killed
24h after MISO injection when most unbound MISO should
have been excreted (Workman, 1980). Additionally, the
histological processing could have been expected to leach out
most, or all, of the unbound drug. We are therefore
identifying the sites of production and subsequent binding of
reactive MISO metabolites in normal tissue. The period of
time from production to binding is too short to allow
significant diffusion of the metabolite from the cell in which
it arose (Chapman et al., 1983; Franko & Koch, 1984).
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Material and methods
The animals used were 10-14-week-old male CBA/H (four)
and female lactating C3H (one) mice. Two of the male mice
and the female were injected with the 3H-MISO; the two
remaining males received unlabelled MISO and the tissues
dissected from all five mice were treated identically.
2-3H- 1-(2-hydroxy-3-methoxy-propyl)-2-nitroimidazole
(3H-MISO) was prepared by the method of Raleigh et al.
(1985). Mice were injected intraperitoneally (i.p.) with
750mg per kg body weight of 3H-MISO (rel. sp. act.
74MBqmg-1), dissolved in phosphate buffered saline. The
mice were killed with i.p. sodium pentobarbitone 24h later.
The following tissues were dissected out from the five
animals and fixed in formalin for ARG: liver, spleen, heart,
lung, oesophagus, pancreas, head (decalcified, parasagittal
sections taken), eye with conjunctival sac and eyelids, back
skin, ear canal, vulva and nipple area of mammary gland
(female). The tissues were routinely processed to 3-5,um
paraffin sections (10-15 sections per tissue) and dipped
in K2 emulsion (Ilford Nuclear Emulsions, Knutsford,
Cheshire, UK). After exposure periods from 1 to 14 weeks
the ARGs were developed, stained with haematoxylin and
eosin (H&E) and scanned to identify tissues of high grain
density for subsequent counting.
The estimate of bound 3H-MISO was made by counting
grains overlying 100jm2 squares of tissue as defined by an
eye-piece graticule. For each tissue, sections were chosen for
counting in which the period of exposure produced less than
40 grains per 100jIm2 in the densest areas. Counts of a
minimum of 500 grains or a maximum of 100 squares were
made for areas of tissue with noticeably high grain densities.
These counts were compared with those in 100 squares over
adjacent areas of 'stroma' composed predominantly of fibro-
blasts, small blood vessels and collagen, thought to represent
background normoxic tissue retention. In all cases the
emulsion background, estimated by counts of 100 squares in
an area near to but off the section, was subtracted. Since
counts on slides exposed for various periods up to 14 weeks
showed no detectable fading of grains over this period the
count of grains per 100jim2 per week could be taken as a
measure of relative specific activity of tritium in the tissues.
No grains in excess of the emulsion background were seen
in preparations of tissues from animals not injected with
3H-MISO.
Results
The grain counts in tissues selected for counting following a
search for high grain count areas are given in Table I
together with results from three low grain count tissues. For
any particular ARG exposure period there was a wide
variation in grain counts between tissues, indicating very
different concentrations of bound MISO. Most of the grains
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Table I Tissue grain counts from mice injected with 3H-MISO
(750mgkg-1), grains per 100jpm2 per exposure weeka
Organ/tissue Ratio organ/tissue
count to stromab
High count tissues
Liver
periportal
centrilobular
Meibomian gland
ducts
acini
Oesophagus
(keratinised layer)
Incisor
(enamel organ)
Nasal septum
(subepithelial gland)
Foot pad
(keratinised layer)
Vomeronasal organ
Sebaceous gland
Lung (airway)
Low count tissues
Hair bulb
Oesophagus (muscle)
Stroma
0.6 (0.06)
2.4 (0.12)
22.1 (2.2)
13.0 (1.6)
12.5 (0.60)
3.5 (0.14)
2.6 (0.20)
1.7 (0.12)
1.7
1.6
1.5
(0.12)
(0.2)
(0.04)
0.15 (0.03)
0.11 (0.03)
0.19 (0.03)
3.2 (0.6)
12.6 (2.0)
116.0 (22)
68.0 (14)
60.6 (5.9)
17.0 (2.2)
13.7 (2.4)
8.9 (1.5)
8.9 (1.5)
8.1 (1.7)
5.7 (0.8)
0.8 (0.4)
0.6 (0.3)
aThe presentation of counts per exposure week allows comparison
of tissues and was assumed valid because of an observed direct
relationship between grain count and period of exposure up to 70
days; bThe stromal count was averaged from a number of tissues. In
no tissue was the stromal count high. Parentheses enclose s.e.
counted probably represented 3H-MISO bound 18-24h pre-
viously since free MISO is cleared rapidly from the body
(T/2-50min). Because of the short path length of the /3
particle (average range in tissue 0.56,um) it has been assumed
that grains in the emulsion represent adduct(s) in the under-
lying cell(s).
Oesophagus
There was an unexpectedly high level of activity in the
stratum corneum, the acellular, keratinised, layer of the
oesophagus (Figure 1). Because the lining of the oesophagus
is being rapidly renewed from beneath, in much the same
way as the surface of the skin, it could be assumed that the
3H-MISO was bound when the observed labelled cells were
deeper, that is, closer to the germinal epithelium. This point
has been confirmed in research at present underway where
mice were killed at 2 or 4h after 3H-MISO injection and the
grains were seen to be predominantly in the strata spinosum
and granulosum.
Foot pad
The distribution in the foot pad (Figure 2) was similar to
oesophagus. The high grain count was at the border-line
between the viable keratocytes and non-viable keratinised
cells of the pad. At the point at which the heavily keratinised
foot pad merged with the much thinner skin of the inter-pad
region the grain count petered out and was no different from
that of the adjacent stroma.
Sebaceous glands
Counts were made in the sebaceous glands of the back, paw,
muzzle and ear canal. In all these tissues there was a high
count (Figure 3) with a tendency to concentrate in the more
degenerate cells which were on the point of being discharged
(holocrine secretion). In some sections grains were observed
along the hair shaft and extending on to the surface of the
skin - presumably this represented sebaceous gland secretion.
Meibomian gland
The meibomian (tarsal) glands in the upper and lower
eyelids were observed in the sections of the eye. These
glands, which are modified sebaceous glands, have ducts
situated at the junction of the conjunctival sac and the skin.
The 3H-MISO was extensively bound to the secretion of
these glands. Twenty-four hours after injection the activity
was predominantly within the collecting ducts (Figure 4).
The counts for the acini were lower- but still much higher
than the local stroma or the liver.
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Figure 1 Oesophagus (ARG). The arrow heads indicate the
band of high grain count over the keratinised layer of the
epidermis. It is likely that binding to the cells took place -20h
previously when these cells lay closer to the germinal layer
(asterisk) (H & E x 260).
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Figure 2 Foot pad (ARG). The grains are over the deep
keratinised layer of the foot pad. The area of lowest oxygen
tension will lie somewhere between the dermal capillaries and the
surface of the foot pad. The thickness of the keratinised layer is
indicated by the two arrow heads (H & E x 120).
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Figure 3 Sebaceous gland (ARG). The cells associated with the
highest grain count (surrounding the asterisk) were degenerate
and on the point of secretion from the gland into the upper half
of the hair follicle (H & E x 120).
Vulva
Significant concentrations of 3H-MISO were observed in the
glands which open just inside the vulva (Figure 5). The
activity was predominantly in the collecting ducts rather
than over the secreting cells.
Enamel organ
The enamel organ of the rodent incisor is active throughout
life. It is seated on a well vascularised bed. There was a high
grain count immediately over the cells in some areas of the
enamel organ (Figure 6). The histological processing caused
much of the enamel itself to be leached out and therefore it
was not known whether MISO uptake occurred within this
tissue.
Vomeronasal organ and nasal subepithelial mucous glands
These two groups of cells in the nasal septum had high grain
counts.
Lung
Throughout most of the lung the grain count was no greater
than the stromal level and other low grain count areas in the
body; however, there was a uniformly high grain count over
the cells lining the airway (Table I). The count appeared the
same in all parts of the airway, from the trachea to the
terminal bronchioles.
Liver
The grain count in the liver was moderate. There was a
Figure 4 Meibomian gland (ARG). The highest grain count is
above the main ducts (arrows) but a high count is also present
over the viable cells of the acini (H & E x 100).
Figure 5 Vulval gland (ARG). The secretion of the glands
contains bound 3H-MISO metabolite (arrows). There are also
g,rains over viablc acinar cells but little above the stroma (H & E
x 100).
gradient from the portal area to a higher count around the
centrilobular vein in most liver lobules.
Hair bulb, oesophageal muscle and other tissues
Counts were made on the hair bulb and the smooth muscle
of the oesophagus as representing tissues with no apparent
areas of high grain count. The counts were similar to the
stromal counts of most high count tissues. Other tissues with
no obvious grain count above stromal level were voluntaryMICROSCOPIC DISTRIBUTION OF MISONIDAZOLE 15
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Figure 6 Enamel organ of the incisor (ARG). High grain counts
are observed above the enamel organ which are the cells between
the arrow heads. The enamel itself has been leached out during
the decalcification of the tissue (asterisk) (H & E x 120).
muscle, bone, cartilage, pituitary, spleen, heart, fat and
brain.
Discussion
MISO is a freely diffusible substance (Ash et al., 1979) which
penetrates well into all tissues (Workman, 1980; Chin &
Rauth, 1981). Whole organ measurements made in rodents
within 2-4h of injection show the highest concentration in
the routes of excretion, i.e. liver/intestine and kidney (Chin
& Rauth, 1981; Rasey et at., 1987). The biological half-life of
MISO in the mouse is in the order of 50min and therefore
by 24h it can be expected that only firmly (covalently)
bound drug will persist.
Franko & Garrecht (1986) observed, 24h after injection,
that labelled (3H or 14C) MISO was at similar levels in
subcutaneous tumour and liver, and at significantly lower
levels in other major tissues/organs. The localised very high
levels of bound MISO we have observed would not be
identified if that tissue had formed only a small part of an
organ/tissue being assayed for MISO by extraction.
Whole-body ARG of 14C-MISO in mice identified activity
at 24h solely in the liver and gastrointestinal tract (Akel et
al., 1986).
It is thought that cellular nitroreductive enzymes either
initiate a one-electron reduction of MISO, which in the
presence of oxygen regenerates MISO (futile reduction), or a
two-electron reductive pathway such as NAD(P)H-dehydro-
genase (lyanasi, 1987), which may be oxygen independent.
Although the metabolic pathway(s) of MISO nitroreduction
are not yet fully understood it is generally accepted that in
conditions of low oxygen tension, and probably those of low
to normal oxygen tension but high nitroreductase activity,
MISO will become covalently bound to macromolecules
close to the site of reduction - probably within the same cell.
We have difficulty explaining some of the findings of the
present study on the basis of the above theories and the
assumed oxygen tensions within the tissues. As far as the
keratinised tissues (oesophagus and foot pad) are concerned
binding might be due to tissue hypoxia. At the estimated
time that binding would have occurred (0-4h post-injection)
our unpublished results using 3H-MISO with a kill at 4h
showed that the labelled cells were closer to the germinal
epithelium, that is, approximately mid-way between the
oxygen diffusing from the dermal capillaries and the atmos-
pheric oxygen at the surface of the tissue (oesophagus and
foot pads). Any hypothesis concerning the change in position
of grains with time (i.e. 4-24 h) should include the codicil
that although the movement seems to indicate the pro-
gression of the cells from the basal to the superficial layers it
is just possible that the bound MISO itself is being trans-
ferred from deeper to more superficial cells. The possibility
of hypoxic cells in skin has previously been suggested
(Brown, 1975; Hendry, 1979; Stone & Withers, 1974). We
are unable at this time to offer an explanation for the clear
accumulation of 3H-MISO in the sebaceous, meibomian and
vulval glands. Although the grain count was highest over the
main ducts of the meibomian and vulval glands and in the
mature sebaceous cells it is likely that the 3H-MISO was
bound to cells when they were closer to the germinal
epithelium and metabolically active. At such a time they
might be expected to be well oxygenated. By the same token
the vomeronasal organ and nasal subepithelial glands were
probably well oxygenated as these tissues are well vascular-
ised. The enamel organ of the incisor is also well vascular-
ised but, as with any such tissue, there could be a stagnation
of blood and a low local oxygen tension.
The raised count in the airway epithelium is intriguing. It
has to be assumed that, at least in the upper airways, the
epithelium was exposed to ambient oxygen tension. The
oxygen tension will be somewhat reduced towards the ter-
minal airways. Again the possibility must be considered of a
local high nitroreductase activity or two electron reductases
or perhaps low levels of superoxide dismutase. The latter
possibility will influence the ability of cellular systems to
remove superoxide via superoxide dismutase - an important
factor in determining the position of equilibrium between
oxygen and one-electron reduced MISO and thereby the
resulting yield of binding metabolites of MISO
(Winterbourn, 1981).
The liver showed a raised grain count and its cells could
be expected to be exposed to blood with one of the lowest
oxygen tensions in the body. Approximately 75% of the
blood entering the liver has already passed through other
tissues which have depleted it of oxygen. Additionally, as the
blood flows from the portal area along the sinusoids to the
centrilobular vein it is further depleted of oxygen. It could
therefore be expected that MISO might be found bound in
the liver with an increasing gradient towards the centre of
the liver lobules - which was what we observed. This may
not be the complete explanation as there are known to exist
gradients of enzymes between the portal area and centri-
lobular vein and the gradient in the grain count may have
been due to one such enzyme and not simply an oxygen
gradient. Our finding of high MISO activity in the liver
confirms that made by previous workers. The explanation
offered by Van Os-Corby et al. (1987) for MISO binding in
mouse liver was low regional oxygen tension. McManus et
al. (1981), on the other hand, have stressed the part played
by the liver enzymes in the metabolism of MISO. The mice
used in the present study were not tumour-bearing and
therefore we are unable to relate the high grain count seen in
some tissues to what might occur in an hypoxic tumour
population. However, 24h whole organ assays of MISO16 L. M. COBB et al.
have given similar levels for tumour (EMT6/ED) and liver
(ratio 1.2; Franko & Garrecht, 1986) while our ratio of
meibomian gland (duct) to liver (centrilobular) zone was 9.2.
Because of its high ARG resolution tritium is an appropri-
ate radionuclide to use for precise localisation of binding but
the positioning of the label on the 2-carbon of the side chain
allows the possibility of side chain cleavage so that some of
the observed bound tritium could be accounted for by
metabolic products of MISO that do not contain the nitro-
imidazole ring or its derivatives. Raleigh et al. (1985)
compared the accumulation in the hypoxic centre of spher-
oids of side-arm labelled 3H-MISO and ring labelled
14C-MISO. They showed that the binding to cells of the two
labelled compounds did not differ significantly over a wide
range of oxygen levels.
A recent publication by Murray et al. (1987) has shown
that MISO given to mice at 1 gkg-1 body weight can
perturb the vasculature of an experimental tumour, although
the growth rate of the tumour is not affected. We have
considered the possibility that MISO in the present study
was in some way having an effect on the vasculature and
possibly oxygenation of the tissues examined. Our current
(unpublished) studies using 75mgkg-1 show the same results
as those reported in this article, where 750mgkg-1 body
weight was used.
With the possible future use of MISO analogues in
diagnostic imaging and as cytotoxic bioreductive agents
activated by hypoxia we need to know the distribution of
these compounds in normal tissues - a point made recently
by Franko (1986) with reference to the use of MISO as a
hypoxic (tumour) cell marker in man. The present study
indicates a tissue distribution of bound MISO adduct which
would not always appear to be consistent with low tissue
oxygen tension. If MISO and analogues become localised in
tissues by processes other than those involving local hypoxia
the use of these compounds to identify hypoxic cells in
tumours would need to be re-examined.
Preliminary data from this work were presented at the Sixth
Conference on Chemical Modifiers of Cancer Treatment, March
1988, Paris. The proceedings of this meeting are to be published in
the International Journal ofRadiation Oncology, Biology and Physics.
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